Archer Investment Corporation’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Archer Investment Corporation's AMGN Position: Q1 2026 in Review
Archer Investment Corporation reduced its Amgen (AMGN) stake by 48% in Q1 2026, selling an estimated $17.1K and leaving 53 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #687.
Archer Investment Corporation first reported a position in AMGN in Q2 2020 and has held it in 24 quarters since. The position peaked at $116K in Q1 2022. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Archer Investment Corporation held 53 shares of Amgen worth $18.6K as of Q1 2026.
- Archer Investment Corporation sold 48 Amgen shares in Q1 2026, an estimated $17.1K.
- Amgen made up ﹤0.01% of Archer Investment Corporation's portfolio in Q1 2026, its #687 holding.
- Archer Investment Corporation first reported a position in Amgen in Q2 2020 and has held it in 24 quarters since.
- Archer Investment Corporation's Amgen position peaked at $116K in Q1 2022.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.